» Articles » PMID: 7559516

Chemical Structure and Translation Inhibition Studies of the Antibiotic Microcin C7

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Oct 6
PMID 7559516
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli microcin C7 (MccC7) is an antibiotic that inhibits protein synthesis in vivo. It is a heptapeptide containing unknown modifications at the N and C termini (García-Bustos, J. F., Pezzi, N., and Méndez, E. (1985) Antimicrob. Agents Chemoth. 27, 791-797). The chemical structure of MccC7 has been characterized by use of 1H homonuclear and heteronuclear (13C, 15N, 31P) nuclear magnetic resonance spectroscopy as well as mass spectrometry (1177 +/- 1 Da). The heptapeptide Met-Arg-Thr-Gly-Asn-Ala-Asp is substituted at the N terminus by a N-formyl group. The C-terminal substituent consists of the phosphodiester of 5'-adenylic acid and n-aminopropanol (AMPap), which is linked via the phosphorus atom to an amide group, thus forming a phosphoramide. The main chain carbonyl of the C-terminal aspartic acid residue is connected via this amide bond to the modified nucleotide unit. MccC7 and the peptide unit inhibit protein translation in vitro while a synthetic analog of the AMPap substituent is not active. Neither the peptide nor the AMPap molecule has an effect on the growth of MccC7-sensible cells. Our results strongly suggest that the peptide is responsible for MccC7 antibiotic activity while the C-terminal substituent is needed for MccC7 transport. Implications of the structure determined in this work for MccC7 synthesis and mode of action are discussed.

Citing Articles

Microcin C7 as a Potential Antibacterial-Immunomodulatory Agent in the Postantibiotic Era: Overview of Its Bioactivity Aspects and Applications.

Yang F, Yang F, Huang J, Yu H, Qiao S Int J Mol Sci. 2024; 25(13).

PMID: 39000321 PMC: 11241378. DOI: 10.3390/ijms25137213.


Engineered reactivity of a bacterial E1-like enzyme enables ATP-driven modification of protein C termini.

Frazier C, Deb D, Weeks A bioRxiv. 2024; .

PMID: 38798401 PMC: 11118369. DOI: 10.1101/2024.05.13.593989.


Engineering and Purification of Microcin C7 Variants Resistant to Trypsin and Analysis of Their Biological Activity.

Yang G, Shang L, Liu L, Li Z, Zeng X, Ding X Antibiotics (Basel). 2023; 12(9).

PMID: 37760643 PMC: 10525924. DOI: 10.3390/antibiotics12091346.


The "Cins" of Our Fathers: Rejuvenated Interest in Colicins to Combat Drug Resistance.

Upatissa S, Mitchell R J Microbiol. 2023; 61(2):145-158.

PMID: 36753040 DOI: 10.1007/s12275-023-00023-x.


Evaluation of Effectiveness and Safety of Microcin C7 in Weaned Piglets.

Shang L, Zhou J, Tu J, Zeng X, Qiao S Animals (Basel). 2022; 12(23).

PMID: 36496787 PMC: 9739829. DOI: 10.3390/ani12233267.